|
1
|
Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies.
|
J Psychiatry Neurosci
|
2009
|
4.16
|
|
2
|
Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
|
Am J Psychiatry
|
2010
|
2.41
|
|
3
|
Serum and plasma BDNF levels in major depression: a replication study and meta-analyses.
|
World J Biol Psychiatry
|
2010
|
1.70
|
|
4
|
Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis.
|
Neurosci Biobehav Rev
|
2007
|
1.67
|
|
5
|
Genetic predictors of response to antidepressants in the GENDEP project.
|
Pharmacogenomics J
|
2009
|
1.35
|
|
6
|
Moderation of antidepressant response by the serotonin transporter gene.
|
Br J Psychiatry
|
2009
|
1.25
|
|
7
|
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis.
|
PLoS Med
|
2012
|
1.19
|
|
8
|
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression.
|
Br J Psychiatry
|
2009
|
1.13
|
|
9
|
Adverse reactions to antidepressants.
|
Br J Psychiatry
|
2009
|
1.12
|
|
10
|
Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.
|
Neuropsychopharmacology
|
2009
|
1.04
|
|
11
|
Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
|
J Affect Disord
|
2011
|
1.03
|
|
12
|
VEGF serum levels in depressed patients during SSRI antidepressant treatment.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2008
|
1.02
|
|
13
|
Self-report and clinician-rated measures of depression severity: can one replace the other?
|
Depress Anxiety
|
2012
|
0.98
|
|
14
|
Body weight as a predictor of antidepressant efficacy in the GENDEP project.
|
J Affect Disord
|
2009
|
0.96
|
|
15
|
Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants.
|
Biol Psychiatry
|
2010
|
0.96
|
|
16
|
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment.
|
Int J Neuropsychopharmacol
|
2009
|
0.96
|
|
17
|
Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.
|
BMC Med
|
2009
|
0.91
|
|
18
|
Genetic differences in cytochrome P450 enzymes and antidepressant treatment response.
|
J Psychopharmacol
|
2013
|
0.91
|
|
19
|
Quality of life in patients with schizophrenia--comparison of self-report and proxy assessments.
|
Soc Psychiatry Psychiatr Epidemiol
|
2004
|
0.91
|
|
20
|
Neuroimaging and electrophysiological studies of the effects of acute tryptophan depletion: a systematic review of the literature.
|
Psychopharmacology (Berl)
|
2006
|
0.88
|
|
21
|
Changes in body weight during pharmacological treatment of depression.
|
Int J Neuropsychopharmacol
|
2010
|
0.87
|
|
22
|
Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.
|
J Psychiatr Res
|
2012
|
0.81
|
|
23
|
Variation in GNB3 predicts response and adverse reactions to antidepressants.
|
J Psychopharmacol
|
2010
|
0.80
|
|
24
|
Genome-wide association analysis accounting for environmental factors through propensity-score matching: application to stressful live events in major depressive disorder.
|
Am J Med Genet B Neuropsychiatr Genet
|
2013
|
0.79
|
|
25
|
History of suicide attempts among patients with depression in the GENDEP project.
|
J Affect Disord
|
2009
|
0.79
|
|
26
|
Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR.
|
World J Biol Psychiatry
|
2011
|
0.78
|
|
27
|
Exploring the role of drug-metabolising enzymes in antidepressant side effects.
|
Psychopharmacology (Berl)
|
2015
|
0.77
|
|
28
|
Genome-wide association study of co-occurring anxiety in major depression.
|
World J Biol Psychiatry
|
2013
|
0.75
|
|
29
|
[Quality of life-proxy (QoL-P)].
|
Epidemiol Psichiatr Soc
|
2003
|
0.75
|
|
30
|
Burnout in nonhospital psychiatric residential facilities.
|
Psychiatr Serv
|
2009
|
0.75
|
|
31
|
Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
|
J Psychopharmacol
|
2014
|
0.75
|